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2001. The survey focused on a subset of applied articles
in English, after excluding methodological, environmen-
tal or veterinarian studies, and those not reporting cost
data. Finally, articles employing MCS for purposes other
than conducting PSA were excluded. Descriptive analyses
were used to evaluate their methods.
RESULTS: Of the 319 articles identiﬁed, 39 met the 
inclusion/exclusion criteria. Of these 39 studies, 64%
were published after 1998. PSA was commonly used to
reﬂect uncertainty regarding probabilities or costs, but
less commonly for utilities. When applicable, the distrib-
ution type was speciﬁed for 42%, 56%, and 64% of
utility, cost, and probability parameters, respectively.
Sixty-one percent of studies used uniform, triangular or
normal distributions. Justiﬁcation for the distribution
type was inconsistently reported. Only 8% of studies
assumed some correlation between parameters or pre-
sented absolute worst- or best-case scenarios, which the-
oretically bound all possible simulation results. Over
70% of studies used acceptability thresholds or curves for
reporting cost-effectiveness results.
CONCLUSIONS: Our survey indicates that the use of
PSA is increasingly popular. However, how these methods
have been applied has rarely been sufﬁciently transpar-
ent. PSA is relatively new in health economics and studies
employing this technique should provide transparent
descriptions of their methods. This will improve the
acceptability and usefulness of PSA, while providing 
guidance to analysts wishing to use this powerful 
methodology.
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In response to European regulators’ concern about the
methodology followed to translate and achieve cultural
adaptation of Health-related Quality of Life (HRQL)
instruments (i.e. the process of adapting a measure from
a source to a target language), the ERIQA Group has inte-
grated the development of regulators-targeted guidance
documents for cross-cultural adaptation into their pro-
gramme. The ﬁrst step in collaboration with Mapi
Research Institute has been to investigate current 
guidelines.
OBJECTIVES: To identify and analyse the methods used
for cultural adaptation of HRQL instruments.
METHODS: Medline and Embase were searched using
the keywords “quality of life”, “questionnaires”, “health
status indicators” which were matched with “translating”
and “cross-cultural comparison”. Papers published
between January 1966 and April 2001 were taken into
consideration. 173 references were identiﬁed. Mapi
Research Institute’s database was searched using “trans-
lation issues”, “cross-cultural comparison”, and “cross-
cultural research”, with 236 references as a result. 409
abstracts were reviewed. Inclusion criteria were: 1) the
paper should propose guidelines/recommendations or 2)
it should review and analyse methods.
RESULTS: 32 papers met with the inclusion criteria. 14
sets of guidelines were identiﬁed. A lack of consensus
emerged about: a) the terminology qualifying the process
of adapting a HRQL instrument from source to target
language, and b) the scope covered by this terminology.
Similarities included multiple forward translations, 
reconciliation sessions, and some form of back-
translations. Differences appeared in the importance
given to back-translation, forms of panel testing, and
translators’ recruitment criteria. Few articles compared
methodologies.
CONCLUSION: This review shows disparity in deﬁni-
tions and methods. Further investigations may be needed
in order to explore empirical evidence of the methods’
effectiveness, and propose recommendations for 
regulators.
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OBJECTIVES: Evaluate the claim that Utility Theory
(UT) is normative.
METHODS: Logical analysis of UT and normative
injunctions. The positive/normative distinction is between
“is” and “ought.” Positive statements describe how
things are; normative injunctions (e.g., “First, cause no
harm”) request that we act in certain ways. The norma-
tive interpretation of UT suggests that we should act so
as to maximize our utility.
RESULTS: The normative interpretation of UT leaves 
the individual with a decision to make: “Should I act so
as to maximize my utility?” If the individual applies UT
as a decision procedure to answer this question, then an
afﬁrmative answer to the question is being assumed and
not proved. Alternatively, the individual could attempt to
justify the use of UT by appealing to a more general deci-
sion procedure. But if the more general decision proce-
dure can decide this question, then why use UT at all?
The more general decision procedure could be used in the
place of UT to decide everyday questions. But, then, the
more general decision procedure requires justiﬁcation. To
justify its use, we must appeal to an even more general
decision procedure. So, we embark upon an inﬁnite
regress when trying to justify UT by appealing to more
general decision procedures. The logical problem with the
normative view of UT does not carry over to medical deci-
sion making in general, where an external criterion is used
as an indicator for a particular characteristic. Vis a vis
medical decision making, the logical problem with the
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normative view of UT derives from its universal sweep
and consequent lack of an external criterion.
CONCLUSIONS: The normative interpretation of UT
leads to circular reasoning or an inﬁnite regress, forcing
the recognition that the normative aspect of UT lies in the
decision to apply UT, not in UT per se.
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mended to effectively incorporate Japan into global OR
plans/protocols: 1) a Japan OR expert should ﬁrst review
draft global OR plans/protocols and prospectively iden-
tify critical success factors in Japan, then 2) Japan OR
expert should draft Japan plans/protocols, and 3) estab-
lish a strong feedback loop from global OR to the Japan
OR expert to incorporate Japan input in global plans/
protocols. Critical success factors in Japan include: 1)
academic expert assistance; 2) feasibility assessment; 3)
institutional commitment; 4) strategic ﬁt with Japan.
Building draft Japan plans/protocols requires a prelimi-
nary assessment of Japan’s medical environment: 1) clin-
ical practice; 2) epidemiology; 3) political, sociological,
ethnic and health care ﬁnancing issues; 4) regulatory
issues. Establishing a strong communication link between
Japan and global OR will ensure that the Japan plans are
integrated into the global OR plans/protocols.
CONCLUSION: Global outcomes research plans/proto-
cols must incorporate Japan. Working with a Japan OR
expert is highly recommended so that global research
plans adequately reﬂect an awareness of critical success
factors and the local medical environment in Japan.
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OBJECTIVES: The last 20 years have seen the develop-
ment of numerous PRO measures mostly however within
and for one culture. Based on the assumption that the
original concepts are universally appropriate, instruments
destined for international use are translated following 
a standardized procedure (linguistic validation). This
process however reveals the interdependence of transla-
tion and original and the importance of integrating an
international component into the design of instruments,
which can be done through a Translatability Assessment.
The presentation will illustrate the methodology and the
advantages of this new approach.
METHODS: A translatability assessment can be deﬁned
as an international critical review of a pre-ﬁnal original
in collaboration with the developer. In the absence of
international development, this may be a cost and time
effective compromise between the WHO approach to
instrument development and translation. The translation
process usually reveals difﬁculties when adapting the
format, instructions, concepts, idiomatic expressions,
response scales or demographic items to different lan-
guages. The translatability assessment proposes to review
these aspects and suggest re-formulations in the original
considering the context and constraints of other lan-
guages/cultures.
RESULTS: Several examples of the impact of the Trans-
latability Assessment on the original wording will be
given. For instance, although the term “work” in English
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Simultaneous global pharmaceutical development, regis-
tration and outcomes research (OR) strategies are now
commonplace. However, incorporating Japan into global
OR plans is a challenge.
OBJECTIVE: This paper addresses the concerns of global
OR researchers by presenting a systematic approach to
incorporating Japan into global research protocols and
strategies.
METHODS: Informal interviews with managers involved
in global R&D or OR planning and a literature review
of pharmacoeconomic studies was conducted. Based on
knowledge gained from several years of actual experience
conducting outcomes research in Japan, these informa-
tion sources were synthesized into a recommended ap-
proach for incorporating Japan into global OR plans.
RESULTS: 39 published studies were found in the 
Japanese and English literature from 1980–2001,
however, no mention of global research protocols was
found. Based on interviews three activities were recom-
